Advanced Phenotypic and Mechanistic Profiling
Perfect for customers interested in a deep understanding of MOA and efficacy.
CDT-OncoPlus™ enhances your understanding of tumor response and drug impact with deeper biological analysis.
What’s Included:
- IRB-approved patient tumor samples
- Annotated sample characterization
- Tumor/immune cell composition profiling
- Cell-subset viability assays
- Dose-response curve analysis*
- Gene Expression Profiling
- Cytokine profiling
- AI-driven modeling (PK/PD, PBPK, QSP)
- Comprehensive report & analysis
🕒 Turnaround: 10–12 days per sample*
